Staining of the endothelial cell marker CD31 three days post AIP treatment revealed a significant reduction in the radius and size variation of vessels in AIP-treated tumors compared with untreated or ICB-treated tumors (Figures 6A and 6B). This evidence concerns the gene PECAM1 and autoimmune pancreatitis.